Aplenzin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0187-5812
  • Package NDC 0187-5812-07
  • Package NDC 0187-5812-30
  • Application number NDA022108
  • SPL ID 45372e42-065d-4d87-89af-d5dcf09c29fb
  • SPL set ID 6494d2d9-0ce4-4126-b1c7-49684395942b
  • UNII E70G3G5863
  • RxCUI 993550
  • RxCUI 993552
  • RxCUI 993567
  • RxCUI 993569
  • RxCUI 993681
  • RxCUI 993683

What the source publishes

Labeler
Bausch Health US, LLC
Active ingredients
bupropion hydrobromide
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb
{
  "name": "Aplenzin",
  "splId": "45372e42-065d-4d87-89af-d5dcf09c29fb",
  "labels": [
    {
      "setId": "6494d2d9-0ce4-4126-b1c7-49684395942b",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6494d2d9-0ce4-4126-b1c7-49684395942b",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6494d2d9-0ce4-4126-b1c7-49684395942b"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Bausch Health US, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)",
      "package_ndc": "0187-5812-07",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20080423"
    },
    {
      "sample": false,
      "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)",
      "package_ndc": "0187-5812-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20080423"
    }
  ],
  "productId": "0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "0187-5812",
  "deaSchedule": null,
  "genericName": "bupropion hydrobromide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BUPROPION HYDROBROMIDE",
      "strength": "522 mg/1"
    }
  ],
  "applicationNumber": "NDA022108",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20080423",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0301875810306",
      "0301875811303"
    ],
    "unii": [
      "E70G3G5863"
    ],
    "rxcui": [
      "993550",
      "993552",
      "993567",
      "993569",
      "993681",
      "993683"
    ],
    "spl_set_id": [
      "6494d2d9-0ce4-4126-b1c7-49684395942b"
    ],
    "manufacturer_name": [
      "Bausch Health US, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb"